Screener
Neurocrine Biosciences NBIX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Neurocrine Biosciences’s reported figures.
Based on the most recent quarter.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
FAQ
- What is Neurocrine Biosciences's price / sales?
- Neurocrine Biosciences (NBIX) reported price / sales of 4.3× in Q1 2026.
- How has Neurocrine Biosciences's price / sales changed year-over-year?
- Neurocrine Biosciences's price / sales decreased by 6.8% year-over-year, from 4.6× to 4.3×.
- What is the long-term trend for Neurocrine Biosciences's price / sales?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's price / sales has grown at a -10.7% compound annual growth rate (CAGR), from 8.7× to 4.9×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Neurocrine Biosciences's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude